This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-04-24 BR&R Conf Call"
Jump to navigation
Jump to search
| Line 57: | Line 57: | ||
====4.1 Lab model (in collaboration with TCB)==== | ====4.1 Lab model (in collaboration with TCB)==== | ||
* Report back from last meeting (Julie E) | * Report back from last meeting (Julie E) | ||
| + | Group to make changes in FHIR regarding the Lab Model. | ||
====4.2 AE Model==== | ====4.2 AE Model==== | ||
Revision as of 13:41, 25 April 2018
|
Related Links |
Attendees
- Boris Brodski (Chair)
- Ed Helton (Chair)
- Hugh Glover (Chair)
- Myron Finseth (Chair, scribe)
- Julia Chen
- Jean Duteau
- Julie Evans
- Bill Friggle
- Norman Gregory
- Smita Hastak
- Wendy Ver Hoef
- Ulli Wagner
- Catherine Hosage Norman
- Robinette Renner
- Hugo Leroux
- Jane Pollack
- Panagiotis Telonis
- Rik Smithies
Agenda Items and notes
1. Minutes Approval
- Approve minutes from conference call on April 10th
Motioned to approve:?? Seconded: ??
2. May WGM Agenda
- Draft is at wc 2018-05-14 BR&R WG Meeting
3. IDMP Substance Resource
- PSS Review and Approval (Boris, Panagiotis)
Motioned to approve: Hugh, Second: Smita Bill Friggle asked to have the PSS sent over the list serve.
4. FHIR
4.1 Lab model (in collaboration with TCB)
- Report back from last meeting (Julie E)
Group to make changes in FHIR regarding the Lab Model.
4.2 AE Model
- FDA use cases (Boris)
4.3 FHIR Tracker Items
- Are there any outstanding?
4.4 Connectathon
5. Action Item List
- Initial draft (Hugh)
6. AOB
- The use of BR&R Wiki
- ???
